I don't beleive that is correct (but happy to be wrong)
mean (average) patients on canagliflozin reduced their risk by 9.5% (i.e.,-1.0divided by 10.1) mean (average) patients on placebo increased their risk by 38.6 % (i.e.,3.9divided by 10.1)
These are correct but we aren't given the scores when strafified so can't know what % decline there is in the high scoring group.
A high score is anything between 20-100% so its just a guessing game for a percentage decline a -5.6% result represents, though it does seeem like i'ts unlikely that taking canagliflozin will bring you down to the medium risk group from high but it would seemily help prevent you from climbing from medium to high.
PIQ Price at posting:
$1.09 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)